Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125724022 | 12572402 | 2 | F | 20160709 | 20160721 | 20160719 | 20160726 | EXP | PHJP2016JP020334 | NOVARTIS | 83.00 | YR | M | Y | 0.00000 | 20160726 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125724022 | 12572402 | 1 | PS | EXELON | RIVASTIGMINE TARTRATE | 1 | Transdermal | 1.9 MG, QD (PATCH2.5CM2/4.5) | 22083 | 1.9 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 125724022 | 12572402 | 2 | SS | EXELON | RIVASTIGMINE TARTRATE | 1 | Transdermal | 4.6 MG, QD (PATCH5 CM2/9MG) | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 125724022 | 12572402 | 3 | SS | EXELON | RIVASTIGMINE TARTRATE | 1 | Transdermal | 6.9 MG, QD (PATCH7.5CM2/ 13.5MG) | 22083 | 6.9 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 125724022 | 12572402 | 4 | SS | EXELON | RIVASTIGMINE TARTRATE | 1 | Transdermal | 4.6 MG, QD (PATCH5 CM2/9MG) | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 125724022 | 12572402 | 5 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, UNK | 0 | 75 | MG | TABLET | |||||||
| 125724022 | 12572402 | 6 | SS | FERROMIA | FERROUS CITRATE | 1 | Unknown | 50 MG, UNK | 0 | 50 | MG | ||||||||
| 125724022 | 12572402 | 7 | SS | MAGMITT | MAGNESIUM OXIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 125724022 | 12572402 | 8 | C | MUCODYNE | CARBOCYSTEINE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125724022 | 12572402 | 1 | Dementia Alzheimer's type |
| 125724022 | 12572402 | 5 | Product used for unknown indication |
| 125724022 | 12572402 | 6 | Product used for unknown indication |
| 125724022 | 12572402 | 7 | Product used for unknown indication |
| 125724022 | 12572402 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125724022 | 12572402 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125724022 | 12572402 | Loss of consciousness | |
| 125724022 | 12572402 | Transient ischaemic attack | |
| 125724022 | 12572402 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125724022 | 12572402 | 1 | 201605 | 0 | ||
| 125724022 | 12572402 | 3 | 201607 | 20160709 | 0 | |
| 125724022 | 12572402 | 4 | 20160711 | 0 |